Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%

Last updated on 2022-06-21 History
Report ID 147622
Drug Identification Number 02141019
Brand name CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 100 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CALCIUM GLUCONATE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100 mL
ATC code B05BB
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-11-01
Actual start date 2021-02-01
Estimated end date 2022-03-07
Actual end date 2022-03-04
Shortage status Resolved
Updated date 2022-06-21
Company comments Effective Mar. 7, 2022, 100mL will be used to cover 100% of 100mL demand plus 100% of 50mL demand on a mL per mL basis for contract customers. Please see customer communication.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v29 2022-06-21 English Compare
v28 2022-03-14 English Compare
v27 2022-03-05 English Compare
v26 2022-03-04 French Compare
v25 2022-03-04 English Compare
v24 2022-02-28 French Compare
v23 2022-02-28 English Compare
v22 2022-02-28 French Compare
v21 2022-02-28 English Compare
v20 2022-02-08 French Compare
v19 2022-02-08 English Compare
v18 2022-02-08 French Compare
v17 2022-02-08 English Compare
v16 2022-02-04 French Compare
v15 2022-02-04 English Compare
v14 2022-01-24 French Compare
v13 2022-01-24 English Compare
v12 2022-01-24 English Compare
v11 2021-12-30 French Compare
v10 2021-12-30 English Compare

Showing 1 to 20 of 29